PharmEnable
11 employees on LinkedIn · 3 known investors
PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address. The company develops first- and best-in-class therapies and originated as a spin-out from the University of Cambridge.
Investors · 3
Frequently asked questions
- What does PharmEnable do?
- PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address. The company develops first- and best-in-class therapies and originated as a spin-out from the University of Cambridge.
- Who are PharmEnable's investors?
- PharmEnable's investors include Cambridge Angels group, Martlet Capital, MC Healthcare Ventures.